業績

• 2023年
• 2022年
• 2021年
• 2020年
• 2019年
• 2018年
• 2017年
• 2016年
• 2015年
• 2014年
• 2013年
• 2012年
• 2011年
• 2010年
• 2009年
• 2008年
• 2007年
• 2006年

2023年

• 原著
• 総説

原著

• Haruyama N, Nakayama M, Fukui A, Yoshitomi R, Tsuruya K, Nakano T, Kitazono T.

  Sex differences in the association between urate metabolism and kidney outcomes in patients with chronic kidney disease.

  Clin Exp Nephrol in press

• Nagae H, Ueno Y, Shojima M, Takae K, Kuroki Y, Katafuchi R.

  Risk factor for progression to kidney failure with replacement therapy in elderly patients with chronic kidney disease: A retrospective single-centre cohort study.
  
  

  Nephrology (Carlton) in press

• Kishimoto H, Nakano T, Torisu K, Tokumoto M, Uchida Y, Yamada S, Taniguchi M, Kitazono T.

  Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway.

  Front Cardiovasc Med 2023 in press.

• Nakagawa K, Tanaka S, Tsuruya K, Kitazono T, Nakano T.

  Association between microscopic hematuria and albuminuria in patients with chronic kidney disease caused by diabetes and hypertension: the Fukuoka Kidney disease Registry Study.

  Clin Exp Nephrol 2023 Mar;27(3):227-235.

• Yamada S, Arase H, Taniguchi M, Kitazono T, Nakano T.

  Simplified geriatric nutritional risk index for assessing nutritional status and stratifying mortality risk in patients receiving maintenance hemodialysis.

  Ther Apher Dial. 2023 Apr;27(2):253-263.

• Seki M, Nakano T, Tanaka S, Matsukuma Y, Funakoshi K, Ohkuma T, Kitazono T.

  Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD).
  
  
  

  Clin Exp Nephrol in press

• Yamada S, Tanaka S, Arase H, Hiyamuta H, Kitamura H, Tokumoto M, Mitsuiki K, Tsuruya K, Kitazono T, Nakano T.

  Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study

  Clin Exp Nephrol In press

• Kitamura H, Tanaka S, Hiyamuta H, Shimamoto S, Tsuruya K, Nakano T, Kitazono T; FKR Study Collaboration Group.

  Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional Study

  Journal of Atherosclerosis and Thrombosis in press

• Yamada S, Tanaka S, Arase H, Hiyamuta H, Kitamura H, Tokumoto M, Mitsuiki K, Tsuruya K, Kitazono T, Nakano T.

  Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study.

  Clin Exp Nephrol In press

• Uchida Y, Nakano T, Kitamura H, Taniguchi M, Tsuruya K, Kitazono T.

  Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort Study.
  

  Clin Exp Nephrol 2023;27(1):79-88.

• Tsuda S, Nakayama M, Tanaka S, Haruyama N, Yoshitomi R, Fukui A, Tsuruya K, Nakano T, Kitazono T.

  The Association of Controlling Nutritional Status Score and Prognostic Nutritional Index with Cardiovascular Diseases: the Fukuoka Kidney Disease Registry Study.

  J Atheroscler Thromb in press

総説

• Nakano T, Kishimoto H, Tokumoto M.

  Direct and indirect effects of fibroblast growth factor 23 on the heart (review).

  Front Endocrinol 2023 in press.